In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Capricor Therapeutics Inc (NASDAQ: CAPR) closed the day trading at $30.04 up 1.18% from the previous closing price of $29.69. In other words, the price has increased by $1.18 from its previous closing price. On the day, 0.91 million shares were traded. CAPR stock price reached its highest trading level at $30.71 during the session, while it also had its lowest trading level at $29.59.
Ratios:
For a better understanding of CAPR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.59 and its Current Ratio is at 3.59. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In the most recent recommendation for this company, Alliance Global Partners on June 30, 2025, initiated with a Buy rating and assigned the stock a target price of $20.
On June 26, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.
On May 20, 2025, Roth Capital started tracking the stock assigning a Buy rating and target price of $31.Roth Capital initiated its Buy rating on May 20, 2025, with a $31 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAPR now has a Market Capitalization of 1634154496 and an Enterprise Value of 1289359744. For the stock, the TTM Price-to-Sale (P/S) ratio is 146.83 while its Price-to-Book (P/B) ratio in mrq is 16.38. Its current Enterprise Value per Revenue stands at 115.84 whereas that against EBITDA is -15.183.
Stock Price History:
The Beta on a monthly basis for CAPR is 0.70, which has changed by 1.1514492 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, CAPR has reached a high of $40.37, while it has fallen to a 52-week low of $4.30. The 50-Day Moving Average of the stock is 117.35%, while the 200-Day Moving Average is calculated to be 192.50%.
Shares Statistics:
Over the past 3-months, CAPR traded about 2.76M shares per day on average, while over the past 10 days, CAPR traded about 1211700 shares per day. A total of 54.40M shares are outstanding, with a floating share count of 47.82M. Insiders hold about 12.11% of the company’s shares, while institutions hold 31.98% stake in the company. Shares short for CAPR as of 1765756800 were 5029282 with a Short Ratio of 1.83, compared to 1763078400 on 14153661. Therefore, it implies a Short% of Shares Outstanding of 5029282 and a Short% of Float of 10.290000000000001.
Earnings Estimates
The stock of Capricor Therapeutics Inc (CAPR) is currently being evaluated by 8.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.44 and low estimates of -$0.57.
Analysts are recommending an EPS of between -$1.9 and -$2.23 for the fiscal current year, implying an average EPS of -$2.13. EPS for the following year is $0.41, with 8.0 analysts recommending between $3.09 and -$2.36.
